These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11519865)

  • 1. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
    Ooka M; Tamaki Y; Sakita I; Fujiwara Y; Yamamoto H; Miyake Y; Sekimoto M; Ohue M; Sugita Y; Miyoshi Y; Ikeda N; Noguchi S; Monden M
    Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
    Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
    Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.
    Bossolasco P; Ricci C; Farina G; Soligo D; Pedretti D; Scanni A; Deliliers GL
    Cancer Detect Prev; 2002; 26(1):60-3. PubMed ID: 12088204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
    Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases.
    Talaat IM; Hachim MY; Hachim IY; Ibrahim RAE; Ahmed MAER; Tayel HY
    Sci Rep; 2020 Aug; 10(1):13061. PubMed ID: 32747636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.
    Zehentner BK; Persing DH; Deme A; Toure P; Hawes SE; Brooks L; Feng Q; Hayes DC; Critichlow CW; Houghton RL; Kiviat NB
    Clin Chem; 2004 Nov; 50(11):2069-76. PubMed ID: 15375015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction.
    Aihara T; Fujiwara Y; Ooka M; Sakita I; Tamaki Y; Monden M
    Breast Cancer Res Treat; 1999 Nov; 58(2):137-40. PubMed ID: 10674878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of micrometastases in lymph nodes from patients with breast cancer.
    Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
    Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
    Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
    Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.
    Zehentner BK; Dillon DC; Jiang Y; Xu J; Bennington A; Molesh DA; Zhang X; Reed SG; Persing D; Houghton RL
    Clin Chem; 2002 Aug; 48(8):1225-31. PubMed ID: 12142378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.
    Ghaffari SR; Sabokbar T; Tahmasebi S; Dastan J; Shorakae S; Moradi A; Tirgari F; Mohagheghi MA; Mosavi-Jarrahi A
    Asian Pac J Cancer Prev; 2006; 7(3):396-8. PubMed ID: 17059329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
    Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
    Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
    Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
    Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.